Literature DB >> 14631372

Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.

Caroline Y L Lai1, Kelvin Y K Chan, Ui-Soon Khoo, Hextan Y S Ngan, Wei-Cheng Xue, Pui Man Chiu, Sai-Wah Tsao, Annie N Y Cheung.   

Abstract

Hydatidiform mole is classified into partial and complete subtypes according to histopathological and genetic criteria. Distinction between the two by histology alone may be difficult. Genetically, a complete mole is diploid without maternal contribution, whereas a partial mole is triploid with a maternal chromosome complement. To assess the accuracy of histological diagnosis by correlating with the genetic composition, we performed fluorescent microsatellite genotyping to detect the presence or absence of maternal genome in a hydatidiform mole and carried out chromosome in situ hybridization to analyze the ploidy. For genotyping analysis, paraffin sections of 36 complete and nine partial moles, diagnosed according to histological criteria, were microdissected and DNA was separately extracted from the decidua and molar villi. Six pairs of primers that flank polymorphic microsatellite repeat sequences on five different chromosomes were used. In all, 34 cases, including 31 complete moles and three partial moles diagnosed histologically, showed no maternal contribution by genotyping; thus these could be genetically considered as complete mole. The other 11 cases (five complete moles and six partial moles previously diagnosed by histology) showed the presence of maternal contribution and were genetically diagnosed as partial moles. The genotyping results correlated with histological evaluation in 88% (37/45) of hydatidiform mole and correlated with chromosome in situ hybridization findings in all the cases, that is, triploid hydatidiform moles had maternal-derived alleles, while diploid hydatidiform moles were purely androgenetic. Compared with genetic diagnosis, histological evaluation was more reliable for the diagnosis of a complete mole (91%, 31/34) than that of a partial mole (55%, 6/11) (P=0.0033). Seven complete moles and three partial moles diagnosed genetically developed gestational trophoblastic neoplasia. To conclude, genotyping and chromosome in situ hybridization can provide reliable adjunct to histology for the classification of a hydatidiform mole, especially in cases with difficult histological evaluation and early gestational age. As a partial mole still carries a risk of developing gestational trophoblastic neoplasia, follow-up is considered necessary for both complete and partial moles.

Entities:  

Mesh:

Year:  2004        PMID: 14631372     DOI: 10.1038/modpathol.3800010

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.

Authors:  Kathleen M Murphy; Thomas G McConnell; Michael J Hafez; Russell Vang; Brigitte M Ronnett
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

2.  Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.

Authors:  Sarah Chiang; Ladan Fazlollahi; Anhthu Nguyen; Rebecca A Betensky; Drucilla J Roberts; A John Iafrate
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

3.  STR DNA genotyping of hydatidiform moles in South China.

Authors:  Xing-Zheng Zheng; Pei Hui; Bin Chang; Zhi-Bin Gao; Yan Li; Bing-Quan Wu; Bo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

4.  Twin gestation with complete hydatidiform mole and a coexisting live fetus: case report and brief review of literature.

Authors:  Raafat Makary; Amir Mohammadi; Marilin Rosa; Sania Shuja
Journal:  Obstet Med       Date:  2010-03-04

5.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

6.  Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.

Authors:  Wei-Cheng Xue; Kelvin Y K Chan; Hui-Chen Feng; Pui-Man Chiu; Hextan Y S Ngan; Sai-Wah Tsao; Annie N Y Cheung
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

7.  Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumor.

Authors:  Sara Jordan; Leslie M Randall; Yevgeniy Karamurzin; Pamela Ward; Fritz Lin; Wendy Brewster; Bradley J Monk
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

8.  Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.

Authors:  P-Y Fong; W-C Xue; H Y S Ngan; P-M Chiu; K Y K Chan; S W Tsao; A N Y Cheung
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

9.  p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.

Authors:  Michelle K Y Siu; Matthew C W Yeung; HuiJuan Zhang; Daniel S H Kong; Joanna W K Ho; Hextan Y S Ngan; Dominic C W Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

10.  Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.

Authors:  Michelle K Y Siu; Esther S Y Wong; Hoi Yan Chan; Hextan Y S Ngan; Kelvin Y K Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.